|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 375.20 INR | +0.27% |
|
-1.38% | -8.90% |
| 04/02 | Aarti Drugs Limited, Q3 2026 Earnings Call, Feb 04, 2026 | |
| 03/02 | Aarti Drugs dividend 2 rupees per share | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | ₹480 | +27.93% | 1 | ||||
| $1,186.19 | +12.1% | 27 | ||||||
| $231.25 | -3.64% | 24 | ||||||
| $245.33 | +9.8% | 27 | ||||||
| CHF 351.3 | -1.43% | 20 | ||||||
| $121.27 | -0.54% | 26 | ||||||
| GBX 209.44 | +9.11% | 21 | ||||||
| CHF 146.49 | -5.26% | 21 | ||||||
| DKK 385.95 | +30.61% | 22 | ||||||
| $341.93 | -11.03% | 27 | ||||||
| $139.46 | -8.55% | 26 | ||||||
| $28.71 | +5.48% | 24 | ||||||
| $59.91 | -3.35% | 23 | ||||||
| $514.32 | +7.62% | 25 | ||||||
| GBX 18.87 | -14.14% | 20 | ||||||
| €99.14 | +23.37% | 23 | ||||||
| JP¥9,153.33 | +6.34% | 15 | ||||||
| JP¥5,263.07 | -4.6% | 15 | ||||||
| CN¥82.91 | +44.67% | 17 | ||||||
| Average | 1,003.1 | +6.55% | 21 | ||||||
| Weighted average by Cap. | 651.68 | +4.60% | 24 |
- Stock Market
- Equities
- AARTIDRUGS Stock
- Sector Aarti Drugs Limited
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition